HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jun Goo Kang Selected Research

theasinensin A

2/2016The heat shock protein 90 inhibitor SNX5422 has a synergistic activity with histone deacetylase inhibitors in induction of death of anaplastic thyroid carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jun Goo Kang Research Topics

Disease

17Type 2 Diabetes Mellitus (MODY)
10/2023 - 01/2010
12Anaplastic Thyroid Carcinoma
05/2017 - 04/2013
7Thyroid Neoplasms (Thyroid Cancer)
11/2020 - 10/2016
5Insulin Resistance
01/2023 - 01/2010
5Obesity
01/2023 - 01/2010
4Hypoglycemia (Reactive Hypoglycemia)
06/2015 - 01/2011
3Body Weight (Weight, Body)
01/2023 - 02/2012
2Hypertension (High Blood Pressure)
08/2023 - 01/2023
2Dyslipidemias (Dyslipidemia)
08/2023 - 01/2023
2Hypotension (Low Blood Pressure)
01/2023 - 01/2022
2Cardiovascular Diseases (Cardiovascular Disease)
11/2022 - 07/2009
2Neoplasms (Cancer)
11/2020 - 04/2013
2Prediabetic State (Prediabetes)
10/2016 - 04/2016
1Gallstones (Gallstone)
08/2023
1Metabolic Syndrome (Dysmetabolic Syndrome X)
08/2023
1Chronic Kidney Failure (Chronic Renal Failure)
01/2023
1Sarcopenia
01/2020
1Carotid Artery Diseases
01/2020
1Tissue Adhesions
01/2018
1Lymphoma (Lymphomas)
02/2017
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
02/2017
1Graves Disease (Basedow Disease)
01/2017
1Hyponatremia
01/2017
1Hemorrhage
01/2017
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2017
1Graves Ophthalmopathy
01/2017
1Shock
01/2017
1Thyroid Diseases (Thyroid Disease)
01/2017
1Diabetes Mellitus
03/2016

Drug/Important Bio-Agent (IBA)

12Glucose (Dextrose)FDA LinkGeneric
01/2023 - 01/2010
8Heat-Shock Proteins (Heat-Shock Protein)IBA
11/2020 - 09/2014
8Proteins (Proteins, Gene)FDA Link
11/2020 - 05/2009
5CholesterolIBA
10/2023 - 07/2009
5Triglycerides (Triacylglycerol)IBA
08/2023 - 07/2009
5Metformin (Glucophage)FDA LinkGeneric
01/2023 - 01/2014
5LipidsIBA
01/2023 - 07/2009
4HDL CholesterolIBA
08/2023 - 05/2014
4LC15-0444IBA
01/2023 - 10/2017
4SurvivinIBA
06/2018 - 02/2015
3Blood Glucose (Blood Sugar)IBA
08/2023 - 08/2010
3ORALIT (ORS)IBA
08/2023 - 01/2020
3Insulin (Novolin)FDA Link
01/2023 - 01/2014
35- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA
11/2020 - 02/2015
3Histone Deacetylase InhibitorsIBA
01/2019 - 02/2015
2dapagliflozinIBA
01/2023 - 01/2023
2lipoprotein cholesterolIBA
01/2023 - 01/2022
2Sodium-Glucose Transport ProteinsIBA
01/2023 - 01/2023
26- chloro- 9- (4- methoxy- 3,5- dimethylpyridin- 2- ylmethyl)- 9H- purin- 2- ylamineIBA
11/2020 - 10/2016
2Histone Deacetylases (Histone Deacetylase)IBA
01/2019 - 02/2016
2evodiamineIBA
01/2019 - 11/2018
2glimepiride (Amarel)FDA LinkGeneric
01/2018 - 01/2014
2Dipeptidyl-Peptidase IV InhibitorsIBA
01/2018 - 10/2017
2Proto-Oncogene Proteins c-bcl-2 (Proto Oncogene Proteins c bcl 2)IBA
10/2017 - 05/2017
2Mitogen-Activated Protein Kinase 3IBA
10/2017 - 02/2017
2Reactive Oxygen Species (Oxygen Radicals)IBA
05/2017 - 02/2017
2Paclitaxel (Taxol)FDA LinkGeneric
05/2017 - 04/2015
2Mitogen-Activated Protein KinasesIBA
05/2017 - 05/2009
2Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
04/2016 - 06/2015
2belinostatIBA
02/2016 - 02/2015
2ApigeninIBA
12/2015 - 04/2013
2herbimycinIBA
10/2015 - 12/2014
2tanespimycin (17AAG)IBA
10/2015 - 04/2015
2Hypoglycemic Agents (Hypoglycemics)IBA
10/2012 - 01/2011
2Thioctic Acid (Lipoic Acid)IBA
05/2009 - 01/2009
2AntioxidantsIBA
05/2009 - 01/2009
1Sodium-Glucose Transporter 2 InhibitorsIBA
01/2023
1SolutionsIBA
01/2023
1Biomarkers (Surrogate Marker)IBA
01/2021
1Hemoglobins (Hemoglobin)IBA
01/2020
1Phosphotransferases (Kinase)IBA
06/2018
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
01/2018
1polypropylene glycol (poly(propylene oxide))IBA
01/2018
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
01/2018
1Polymethyl Methacrylate (Sol)IBA
01/2018
1HydrogelsIBA
01/2018
1Poloxamer (Poloxamer 407)IBA
01/2018
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2018
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2018
14- (3- amino- 4- (2,4,5- trifluorophenyl)butanoyl)- 3- (tert- butoxymethyl)piperazin- 2- oneIBA
12/2017
1Adenosine Monophosphate (AMP)IBA
10/2017
1Protein Kinases (Protein Kinase)IBA
10/2017
1celastrolIBA
05/2017
1Death Domain ReceptorsIBA
05/2017
1C-Reactive ProteinIBA
03/2017
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
02/2017
1Janus Kinase 2IBA
02/2017
1Doxorubicin (Adriamycin)FDA LinkGeneric
02/2017
1cucurbitacin BIBA
02/2017
1Immunoglobulins (Immunoglobulin)IBA
01/2017
1CreatinineIBA
01/2017
1TerlipressinIBA
01/2017
1Immunoglobulin G (IgG)IBA
01/2017
1SodiumIBA
01/2017
1triptolideIBA
10/2016
1Histone Acetyltransferases (Histone Acetyltransferase)IBA
10/2016

Therapy/Procedure

3Therapeutics
01/2023 - 01/2014
2Cholecystectomy
08/2023 - 01/2023
1Operative Surgical Procedures
08/2023
1Glycemic Control
01/2023
1Injections
01/2018